The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development – The Authors' Reply

Author： DiMasi Joseph A. Paquette Cherie

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.23, Iss.12, 2005-01, pp. : 1193-1202

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comment on “The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development”

By Hollis Aidan

PharmacoEconomics, Vol. 23, Iss. 12, 2005-01 ,pp. : 1187-1192

Adis International

Access to resources Recommend Favorite

Health economics in drug development

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 412, 2003-01 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

The Future Costs, Risks and Rewards of Drug Development: The Economics of Pharmacogenomics

By Cook Joseph

PharmacoEconomics, Vol. 27, Iss. 5, 2009-05 ,pp. : 355-363

Adis International

Access to resources Recommend Favorite

Aptamers Building a Role in Research and Drug Development

By Adis International Limited

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 1, 2005-01 ,pp. : 3-7

Adis International

Access to resources Recommend Favorite

Pharmacogenomics research: a potential strategy for drug development

By Wen Jia-Gen Wu Lin Pu Xin-Xiang He Fa-Zhong Liu Mou-Ze Zhou Hong-Hao Zhang Wei

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 7, 2015-07 ,pp. : 437-445

Govi-Verlag

Access to resources Recommend Favorite